Welcome to our dedicated page for CANSORTIUM news (Ticker: CNTMF), a resource for investors and traders seeking the latest updates and insights on CANSORTIUM stock.
Cansortium Inc (CNTMF) is a leading multi-state operator in the cannabis sector, focusing on cultivation, processing, and dispensing high-quality medical and recreational cannabis products. With a strong presence in key markets like Florida, New York, and Pennsylvania, Cansortium is dedicated to providing patients and consumers with innovative and effective cannabis solutions. The company's robust financial position, strategic partnerships, and commitment to compliance and sustainability set it apart in the industry.
Cansortium Inc. (CSE: TIUM.U, OTCQX: CNTMF), a multi-state cannabis company operating under the Fluent™ brand, will host a conference call on May 1, 2023, at 4:30 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2022. A press release detailing these results will be issued before the call. Interested parties can email questions to investors@cansortiuminc.com. The call can be accessed via toll-free and international numbers provided, along with a conference ID. A replay will also be available on Cansortium's investor relations website.
Cansortium operates in Florida, Pennsylvania, and Texas, focusing on operational excellence in cultivation, production, distribution, and retail.
Cansortium, operating under the Fluent brand, announces the grand opening of its 30th Florida medical cannabis dispensary at 763 Atlantic Blvd, Jacksonville, on March 17, 2023. This location aims to enhance patient access, as Jacksonville has shown strong patient retention rates in existing stores. Furthermore, Cansortium plans to expand with a fourth Jacksonville location later this year. The new dispensary, occupying 2,585 sq. ft., will offer a full range of cannabis products and features an online ordering system for convenient pick-up. During the opening weekend, all products will be available at a 50% discount, attracting new customers.
Cansortium Inc. (OTCQX: CNTMF) announced the appointment of Jeffrey Batliner as the new Chief Financial Officer, effective March 14, 2023, succeeding Liora Boudin. Batliner brings over 25 years of financial expertise, having previously served as CFO at Unrivaled Brands, where he successfully managed acquisition integrations and cash flow. CEO Robert Beasley expressed confidence in Batliner's ability to lead the company's financial operations and support growth objectives. Cansortium operates under the Fluent™ brand, with a commitment to operational excellence in the cannabis industry across Florida, Pennsylvania, and Texas.
Cansortium Inc. (OTCQX: CNTMF) has successfully completed a non-brokered private placement, raising US$3 million by issuing 30 million units at US$0.10 each on
Cansortium Inc. (OTCQX: CNTMF) has partnered with Origins TK Selects to enhance its cannabis genetic offerings in Florida. The collaboration will initially provide patients with Origins OG Kush and Origins Triangle Kush, launched at 29 Fluent dispensaries starting February 25, 2023. This partnership aims to broaden access to high-quality cannabis strains through Fluent's legacy growers, Freedom Town Holdings. Additionally, select Fluent locations will showcase TK's artwork, enriching the consumer experience in the Sunshine State. Cansortium operates in multiple states, focusing on operational excellence in cannabis cultivation and retail.
Cansortium, operating under the Fluent brand, announces the grand opening of its 29th medical cannabis dispensary in Pensacola, Florida, on January 20, 2023. This location expands the company's retail presence to 32 outlets nationwide and enhances patient access to medical cannabis products. The new dispensary will offer a 50% discount on products during its opening weekend, featuring a range of cannabis products including edibles, tinctures, and more. Fluent plans to open three additional locations in Florida in the first half of 2023, further strengthening its market position while creating over 540 jobs.
Cansortium Inc. reported Q3 2022 revenue of $22.1 million, a 42% increase YoY, and an Adjusted EBITDA of $11.7 million, more than double from a year ago. The company achieved a 71% growth in adjusted gross profit, totaling $16.7 million. Despite store closures due to Hurricane Ian, Cansortium anticipates continued expansion in Florida and Pennsylvania, with plans to enter Texas. However, revenue guidance for 2022 has been revised down to $85-$90 million from $90-$95 million. As of September 30, 2022, total debt stood at $69.4 million.
Cansortium Inc. (OTCQX: CNTMF) will host a conference call on November 29, 2022, at 4:30 p.m. ET to discuss its Q3 2022 financial results ending September 30, 2022. A press release with these results will be issued prior to the call. Interested parties can join via toll-free and international dial-in numbers or through the provided conference link. The call will include a Q&A session post-presentation. Cansortium operates under the Fluent™ brand, focusing on delivering high-quality cannabis products in Florida, Pennsylvania, and Texas.
FAQ
What is the current stock price of CANSORTIUM (CNTMF)?
What is the market cap of CANSORTIUM (CNTMF)?
What is Cansortium Inc's primary focus?
In which key markets does Cansortium operate?
What sets Cansortium apart in the cannabis industry?
How can investors get in touch with Cansortium's CEO?
Where can investors find more information about Cansortium Inc?
What is Cansortium's outstanding debt composition?
What is the cash position net of debt for Cansortium Inc?
How does Cansortium calculate adjusted gross profit?
What drives Cansortium's success in the cannabis industry?